info@marketresearchfuture.com   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)
Certified Global Research Member
Isomar 1 Iso 1
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Infection Control in Air Market Research Report Information By Activated Carbon, Ion And Ozone Generators, And UV Products), By Sales Service (Regular Sales And After Sales Services), By End-User (Commercial And Residential) By Distribution Channel (Offline Channel And Online Channels),And By Region (North America, Europe, Asia-Pacific, Middle East & Africa, And South America) –Market Forecast Till 2035


ID: MRFR/F-B & N/53592-CR | 129 Pages | Author: Harshita Gorade| June 2025

         Global Outlook (USD Billion, 2028-2035)


                Global Infection Control in Air, By Type (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                Global Infection Control in Air, By End-User (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                Global Infection Control in Air, By Sales Service (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                Global Infection Control in Air, By Distribution Channel (USD Billion, 2028-2035)



  • Offline

  • Online


                North America Outlook (USD Billion, 2028-2035)


                North America Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                North America Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


               


                North America Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


               


                North America Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                U.S. Outlook (USD Billion, 2028-2035)


                U.S. Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                U.S. Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                U.S. Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                U.S. Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                Canada Outlook (USD Billion, 2028-2035)


                Canada Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                Canada Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                Canada Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                Canada Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                Mexico Outlook (USD Billion, 2028-2035)


                Mexico Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                Mexico Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                Mexico Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                Mexico Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                Europe Outlook (USD Billion, 2028-2035)


                Europe Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                Europe Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                Europe Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                Europe Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                Germany Outlook (USD Billion, 2028-2035)


                Germany Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                Germany Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                Germany Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                Germany Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                France Outlook (USD Billion, 2028-2035)


                France Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                France Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                France Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                France Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                U.K. Outlook (USD Billion, 2028-2035)


                U.K. Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                U.K. Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                U.K. Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                U.K. Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                Italy Outlook (USD Billion, 2028-2035)


                Italy Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                Italy Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                Italy Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                Italy Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                Spain Outlook (USD Billion, 2028-2035)


                Spain Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                Spain Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                Spain Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                Spain Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                RoE Outlook (USD Billion, 2028-2035)


                RoE Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                RoE Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                RoE Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                RoE Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                Asia-Pacific Outlook (USD Billion, 2028-2035)


                Asia-Pacific Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                Asia-Pacific Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                Asia-Pacific Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                Asia-Pacific Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                China Outlook (USD Billion, 2028-2035)


                China Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                China Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                China Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                China Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                Japan Outlook (USD Billion, 2028-2035)


                Japan Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                Japan Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                Japan Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                Japan Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                India Outlook (USD Billion, 2028-2035)


                India Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                India Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                India Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                India Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                South Korea Outlook (USD Billion, 2028-2035)


                South Korea Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                South Korea Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                South Korea Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                South Korea Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                Australia and New Zealand Outlook (USD Billion, 2028-2035)


                Australia and New Zealand Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                Australia and New Zealand Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                Australia and New Zealand Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                Australia and New Zealand Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                RoAPAC Outlook (USD Billion, 2028-2035)


                RoAPAC Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                RoAPAC Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                RoAPAC Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                RoAPAC Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                Middle East and Africa Outlook (USD Billion, 2028-2035)


                Middle East and Africa Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                Middle East and Africa Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                Middle East and Africa Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                Middle East and Africa Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                GCC Outlook (USD Billion, 2028-2035)


                GCC Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                GCC Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                GCC Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                GCC Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                Turkey Outlook (USD Billion, 2028-2035)


                Turkey Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                Turkey Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                Turkey Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                Turkey Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                Northern Africa Outlook (USD Billion, 2028-2035)


                Northern Africa Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                Northern Africa Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                Northern Africa Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                Northern Africa Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                Southern Africa Outlook (USD Billion, 2028-2035)


                Southern Africa Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                Southern Africa Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                Southern Africa Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                Southern Africa Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                South America Outlook (USD Billion, 2028-2035)


                South America Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                South America Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                South America Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                South America Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                Argentina Outlook (USD Billion, 2028-2035)


                Argentina Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                Argentina Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                Argentina Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                Argentina Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                Brazil Outlook (USD Billion, 2028-2035)


                Brazil Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                Brazil Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                Brazil Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                Brazil Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online


                RoSA Outlook (USD Billion, 2028-2035)


                RoSA Infection Control in Air, 0 (USD Billion, 2028-2035)



  • HEPA

  • Activated Carbon

  • Ion and Ozone Generator

  • UV


                RoSA Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Commercial

  • Residential

  • Ion and Ozone Generator


                RoSA Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Regular

  • After Sales Service


                RoSA Infection Control in Air, 0 (USD Billion, 2028-2035)



  • Offline

  • Online

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 MARKET ATTRACTIVENESS ANALYSIS

1.1.1 GLOBAL INFECTION CONTROL IN AIR MARKET, BY TYPE

1.1.2 GLOBAL INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE

1.1.3 GLOBAL INFECTION CONTROL IN AIR MARKET, BY END-USER

1.1.4 GLOBAL INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL

1.1.5 GLOBAL INFECTION CONTROL IN AIR MARKET, BY REGION

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 MARKET STRUCTURE

2.4 KEY IMPLEMENTATION CRITERIA

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

4.1 INTRODUCTION

4.2 DRIVERS

4.2.1 GROWING AWARENESS OF AIRBORNE INFECTIONS

4.2.2 RISING HEALTHCARE CONCERN

4.2.3 REGULATORY COMPLIANCE

4.2.4 PANDEMIC PREPAREDNESS

4.2.5 SOARING DEMAND FOR HEPA FILTERS IN RESIDENTIAL SETTINGS

4.3 RESTRAINTS

4.3.1 HEALTH CONCERNS WITH OZONE GENERATORS

4.3.2 INITIAL COST AND MAINTENANCE EXPENSES

4.4 OPPORTUNITIES

4.4.1 INCREASING DEMAND IN NON-HEALTHCARE SECTORS

4.4.2 CUSTOMIZED SOLUTIONS FOR SPECIFIC SETTINGS

4.4.3 INTEGRATION OF MULTIPLE TECHNOLOGIES, RAPID URBANIZATION AND INDUSTRIALIZATION

5 MARKET FACTOR ANALYSIS

5.1 SUPPLY/VALUE CHAIN ANALYSIS

5.1.1 RAW MATERIALS AND COMPONENT SUPPLIERS:

5.1.2 MANUFACTURERS:

5.1.3 TECHNOLOGY PROVIDERS:

5.1.4 DISTRIBUTION AND LOGISTICS:

5.1.5 REGULATORY COMPLIANCE AND CERTIFICATION:

5.1.6 END-USERS:

5.1.7 AFTERMARKET SERVICES:

5.2 PORTER FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS:

5.2.2 BARGAINING POWER OF BUYERS:

5.2.3 BARGAINING POWER OF SUPPLIERS:

5.2.4 THREAT OF SUBSTITUTE PRODUCTS:

5.2.5 INTENSITY OF COMPETITIVE RIVALRY:

5.2.6 GOVERNMENT AND REGULATORY INFLUENCE:

5.2.7 TECHNOLOGICAL ADVANCEMENTS:

5.2.8 GLOBAL HEALTH CONCERNS:

5.3 IMPACT OF COVID-19 OUTBREAK ON AIR PURIFIER MARKET

5.3.1 IMPACT ON PRODUCTION:

5.3.2 IMPACT ON SUPPLY CHAIN:

5.3.3 IMPACT ON PRICING:

5.3.4 OTHER IMPACTS:

6 GLOBAL INFECTION CONTROL IN AIR MARKET, BY TYPE

6.1 INTRODUCTION

6.2 HEPA

6.3 ACTIVATED CARBON

6.4 ION AND OZONE GENERATOR

6.5 UV

7 GLOBAL INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE

7.1 INTRODUCTION

7.2 REGULAR SALES

7.3 AFTER SALES SERVICE

8 GLOBAL INFECTION CONTROL IN AIR MARKET, BY END-USER

8.1 INTRODUCTION

8.2 COMMERCIAL (INCLUDING INDUSTRIAL)

8.3 RESIDENTIAL

9 GLOBAL INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL

9.1 INTRODUCTION

9.2 OFFLINE

9.3 ONLINE

10 GLOBAL INFECTION CONTROL IN AIR MARKET, BY REGION

10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 U.S.

10.2.2 CANADA

10.2.3 MEXICO

10.3 EUROPE

10.3.1 GERMANY

10.3.2 FRANCE

10.3.3 U.K.

10.3.4 ITALY

10.3.5 SPAIN

10.3.6 REST OF EUROPE

10.4 ASIA-PACIFIC

10.4.1 CHINA

10.4.2 JAPAN

10.4.3 INDIA

10.4.4 SOUTH KOREA

10.4.5 AUSTRALIA AND NEW ZEALAND

10.4.6 REST OF ASIA-PACIFIC

10.5 MIDDLE EAST AND AFRICA

10.5.1 GCC

10.5.2 TURKEY

10.5.3 NORTHERN AFRICA

10.5.4 SOUTHERN AFRICA

10.6 SOUTH AMERICA

10.6.1 BRAZIL

10.6.2 ARGENTINA

10.6.3 ROSA

11 COMPETITIVE LANDSCAPE

11.1 MARKET SHARE ANALYSIS

11.2 COMPETITIVE DASHBOARD

11.3 COMPETITIVE MARKET POSITIONING

12 COMPANY PROFILES

12.1 MANN+HUMMEL

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS AND SERVICES

12.1.4 SWOT ANALYSIS

12.1.5 KEY STRATEGIES

12.2 AFPRO

12.2.1 COMPANY OVERVIEW

12.2.2 FINANCIAL OVERVIEW

12.2.3 PRODUCTS AND SERVICES

12.2.4 SWOT ANALYSIS

12.2.5 KEY STRATEGIES

12.3 AMERICAN AIR FILTER COMPANY, INC

12.3.1 COMPANY OVERVIEW

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS AND SERVICES

12.3.4 SWOT ANALYSIS

12.3.5 KEY STRATEGIES

12.4 AIROCIDE

12.4.1 COMPANY OVERVIEW

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS AND SERVICES

12.4.4 SWOT ANALYSIS

12.4.5 KEY STRATEGIES

12.5 BSH HOME APPLIANCES GROUP

12.5.1 COMPANY OVERVIEW

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS AND SERVICES

12.5.4 SWOT ANALYSIS

12.5.5 KEY STRATEGIES

12.6 DAIKIN

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL OVERVIEW

12.6.3 PRODUCTS AND SERVICES

12.6.4 SWOT ANALYSIS

12.6.5 KEY STRATEGIES

12.7 HISENSE INTERNATIONAL

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS AND SERVICES

12.7.4 SWOT ANALYSIS

12.7.5 KEY STRATEGIES

12.8 IQAIR

12.8.1 COMPANY OVERVIEW

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS AND SERVICES

12.8.4 SWOT ANALYSIS

12.8.5 KEY STRATEGIES

12.9 TEKA

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS AND SERVICES

12.9.4 SWOT ANALYSIS

12.9.5 KEY STRATEGIES

LIST OF TABLES

TABLE 1 GLOBAL INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 2 GLOBAL INFECTION CONTROL IN AIR MARKET, BY ACTIVATED CARBON, BY REGION, 2018–2035 (USD BILLION)

TABLE 3 GLOBAL INFECTION CONTROL IN AIR MARKET, BY ACTIVATED CARBON, BY REGION, 2018–2035 (USD BILLION)

TABLE 4 GLOBAL INFECTION CONTROL IN AIR MARKET, BY ION AND OZONE GENERATOR, BY REGION, 2018–2035 (USD BILLION)

TABLE 5 GLOBAL INFECTION CONTROL IN AIR MARKET, BY UV, BY REGION, 2018–2035 (USD BILLION)

TABLE 6 GLOBAL INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018–2035 (USD BILLION)

TABLE 7 GLOBAL INFECTION CONTROL IN AIR MARKET, THROUGH REGULAR SALES, BY REGION, 2018–2035 (USD BILLION)

TABLE 8 GLOBAL INFECTION CONTROL IN AIR MARKET, THROUGH AFTER SALES SERVICE, BY REGION, 2018–2035 (USD BILLION)

TABLE 9 GLOBAL INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 10 GLOBAL INFECTION CONTROL IN AIR MARKET, THROUGH COMMERCIAL (INCLUDING INDUSTRIAL), BY REGION, 2018–2035 (USD BILLION)

TABLE 11 GLOBAL INFECTION CONTROL IN AIR MARKET, THROUGH RESIDENTIAL, BY REGION, 2018–2035 (USD BILLION)

TABLE 12 GLOBAL INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018–2035 (USD BILLION)

TABLE 13 GLOBAL INFECTION CONTROL IN AIR MARKET, THROUGH OFFLINE, BY REGION, 2018–2035 (USD BILLION)

TABLE 14 GLOBAL INFECTION CONTROL IN AIR MARKET, THROUGH ONLINE, BY REGION, 2018–2035 (USD BILLION)

TABLE 15 GLOBAL INFECTION CONTROL IN AIR MARKET, BY REGION, 2018–2035 (USD BILLION)

TABLE 16 NORTH AMERICA: INFECTION CONTROL IN AIR MARKET, BY COUNTRY, 2018-2035 (USD BILLION)

TABLE 17 NORTH AMERICA: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 18 NORTH AMERICA: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 19 NORTH AMERICA: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 20 NORTH AMERICA: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 21 U.S.: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 22 U.S.: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 23 U.S.: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 24 U.S.: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 25 CANADA: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 26 CANADA: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 27 CANADA: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 28 CANADA: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 29 MEXICO: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 30 MEXICO: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 31 MEXICO: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 32 MEXICO: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 33 EUROPE: INFECTION CONTROL IN AIR MARKET, BY COUNTRY, 2018-2035 (USD BILLION)

TABLE 34 EUROPE: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 35 EUROPE: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 36 EUROPE: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 37 EUROPE: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 38 GERMANY: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 39 GERMANY: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 40 GERMANY: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 41 GERMANY: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 42 FRANCE: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 43 FRANCE: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 44 FRANCE: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 45 FRANCE: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 46 U.K.: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 47 U.K.: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 48 U.K.: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 49 U.K.: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 50 ITALY: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 51 ITALY: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 52 ITALY: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 53 ITALY: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 54 SPAIN: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 55 SPAIN: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 56 SPAIN: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 57 SPAIN: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 58 ROE: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 59 ROE: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 60 ROE: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 61 ROE: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 62 ASIA-PACIFIC: INFECTION CONTROL IN AIR MARKET, BY COUNTRY, 2018-2035 (USD BILLION)

TABLE 63 ASIA-PACIFIC: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 64 ASIA-PACIFIC: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 65 ASIA-PACIFIC: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 66 ASIA-PACIFIC: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 67 CHINA: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 68 CHINA: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 69 CHINA: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 70 CHINA: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 71 JAPAN: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 72 JAPAN: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 73 JAPAN: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 74 JAPAN: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 75 INDIA: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 76 INDIA: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 77 INDIA: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 78 INDIA: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 79 SOUTH KOREA: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 80 SOUTH KOREA: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 81 SOUTH KOREA: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 82 SOUTH KOREA: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 83 AUSTRALIA AND NEW ZEALAND: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 84 AUSTRALIA AND NEW ZEALAND: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 85 AUSTRALIA AND NEW ZEALAND: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 86 AUSTRALIA AND NEW ZEALAND: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 87 REST OF ASIA-PACIFIC: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 88 REST OF ASIA-PACIFIC: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 89 REST OF ASIA-PACIFIC: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 90 REST OF ASIA-PACIFIC: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 91 MIDDLE EAST AND AFRICA: INFECTION CONTROL IN AIR MARKET, BY COUNTRY, 2018-2035 (USD BILLION)

TABLE 92 MIDDLE EAST AND AFRICA: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 93 MIDDLE EAST AND AFRICA: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 94 MIDDLE EAST AND AFRICA: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 95 MIDDLE EAST AND AFRICA: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 96 GCC: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 97 GCC: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 98 GCC: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 99 GCC: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 100 TURKEY: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 101 TURKEY: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 102 TURKEY: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 103 TURKEY: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 104 NORTHERN AFRICA: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 105 NORTHERN AFRICA: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 106 NORTHERN AFRICA: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 107 NORTHERN AFRICA: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 108 SOUTHERN AFRICA: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 109 SOUTHERN AFRICA: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 110 SOUTHERN AFRICA: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 111 SOUTHERN AFRICA: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 112 SOUTH AMERICA: INFECTION CONTROL IN AIR MARKET, BY COUNTRY, 2018-2035 (USD BILLION)

TABLE 113 SOUTH AMERICA: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 114 SOUTH AMERICA: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 115 SOUTH AMERICA: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 116 SOUTH AMERICA: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 117 BRAZIL: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 118 BRAZIL: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 119 BRAZIL: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 120 BRAZIL: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 121 ARGENTINA: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 122 ARGENTINA: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 123 ARGENTINA: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 124 ARGENTINA: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)

TABLE 125 ROSA: INFECTION CONTROL IN AIR MARKET, BY TYPE, 2018-2035 (USD BILLION)

TABLE 126 ROSA: INFECTION CONTROL IN AIR MARKET, BY END-USER, 2018-2035 (USD BILLION)

TABLE 127 ROSA: INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2018-2035 (USD BILLION)

TABLE 128 ROSA: INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2018-2035 (USD BILLION)
LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL INFECTION CONTROL IN AIR

FIGURE 3 GLOBAL INFECTION CONTROL IN AIR ANALYSIS BY TYPE

FIGURE 4 GLOBAL INFECTION CONTROL IN AIR MARKET ANALYSIS BY SALES SERVICE

FIGURE 5 GLOBAL INFECTION CONTROL IN AIR MARKET ANALYSIS BY END-USER

FIGURE 6 GLOBAL INFECTION CONTROL IN AIR MARKET ANALYSIS BY DISTRIBUTION CHANNEL

FIGURE 7 GLOBAL INFECTION CONTROL IN AIR ANALYSIS BY REGION, 2022

FIGURE 8 GLOBAL INFECTION CONTROL IN AIR MARKET: MARKET STRUCTURE

FIGURE 9 KEY BUYING CRITERIA OF INFECTION CONTROL IN AIR REPORT

FIGURE 1 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 2 MARKET DYNAMIC ANALYSIS OF THE GLOBAL INFECTION CONTROL IN AIR MARKET

FIGURE 3 SUPPLY / VALUE CHAIN: GLOBAL INFECTION CONTROL IN AIR MARKET

FIGURE 4 PORTER FIVE FORCES ANALYSIS

FIGURE 5 GLOBAL INFECTION CONTROL IN AIR MARKET, BY TYPE, 2022 (% SHARE), 2022 VS 2032 (USD BILLION)

FIGURE 6 GLOBAL INFECTION CONTROL IN AIR MARKET, BY SALES SERVICE, 2022 (% SHARE), 2022 VS 2032 (USD BILLION)

FIGURE 7 GLOBAL INFECTION CONTROL IN AIR MARKET, BY END-USER, 2022 (% SHARE), 2022 VS 2032 (USD BILLION)

FIGURE 8 GLOBAL INFECTION CONTROL IN AIR MARKET, BY DISTRIBUTION CHANNEL, 2022 (% SHARE), 2022 VS 2032 (USD BILLION)

FIGURE 9 GLOBAL INFECTION CONTROL IN AIR MARKET, BY REGION, 2022 (% SHARE) 2022 VS 2032 (USD BILLION)

FIGURE 10 NORTH AMERICA: INFECTION CONTROL IN AIR MARKET, BY COUNTRY, 2022 (% SHARE)

FIGURE 11 EUROPE: INFECTION CONTROL IN AIR MARKET, BY COUNTRY, 2022 (% SHARE)

FIGURE 12 ASIA-PACIFIC: INFECTION CONTROL IN AIR MARKET, BY COUNTRY, 2022 (% SHARE)

FIGURE 13 MIDDLE EAST AND AFRICA: INFECTION CONTROL IN AIR MARKET, BY COUNTRY, 2022 (% SHARE)

FIGURE 14 SOUTH AMERICA: INFECTION CONTROL IN AIR MARKET, BY COUNTRY, 2022 (% SHARE)

FIGURE 15 MARKET SHARE ANALYSIS, 2022

FIGURE 16 COMPETITION DASHBOARD

FIGURE 17 MANN+HUMMEL:SWOT ANALYSIS

FIGURE 18 AFPRO: SWOT ANALYSIS

FIGURE 19 AMERICAN AIR FILTER COMPANY, INC: SWOT ANALYSIS

FIGURE 20 AIROCIDE: SWOT ANALYSIS

FIGURE 21 BSH HOME APPLIANCES GROUP: SWOT ANALYSIS

FIGURE 22 DAIKIN: SWOT ANALYSIS

FIGURE 23 HISENSE INTERNATIONAL: SWOT ANALYSIS

FIGURE 24 IQAIR: SWOT ANALYSIS

FIGURE 25 TEKA: SWOT ANALYSIS

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
report-img